Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2024 Jun 18;26(Suppl 4):0. doi: 10.1093/neuonc/noae064.224

EPEN-22. ZFTA FUSION ONCOPROTEINS DRIVE ONCOGENESIS THROUGH ASSEMBLY OF BIOMOLECULAR CONDENSATES

Srinidhi Varadharajan 1, Amir Arabzade 2, Hazheen K Shirnekhi 3, Siri Ippagunta 4, Nic Laboe 5, David Gee 6, Erik Emanus 7, Alisha Kardian 8, Aaron H Phillips 9, Swarnendu Tripathi 10, Abbas Shirinifard 11, Becky Petersen 12, Sharon King 13, Daniel Stabley 14, Aaron Pitre 15, George Campbell 16, Cheon-Gil Park 17, Adam D Durbin 18, Jun Qi 19, Kelsey Bertrand 20, Michael D Taylor 21, Paul A Northcott 22, Benjamin Deneen 23, Aseem Z Ansari 24, Richard W Kriwacki 25, Stephen C Mack 26
PMCID: PMC11182982

Abstract

BACKGROUND

Ependymomas continue to be an aggressive brain tumor entity without targeted therapies. The highly recurrent fusion oncoprotein (FO), ZFTA-RELA, is known to be associated with about 70% of supratentorial ependymomas. While recent studies have highlighted that the fusion protein is involved in aberrant DNA binding and subsequent oncogenic gene expression, the precise mechanisms underlying the transcriptional dysregulation remain elusive.

METHODS

Using super-resolution and lattice-sheet microscopy, we demonstrate that ZFTA-RELA forms dynamic liquid-like nuclear condensates. ZFTA-RELA condensates recruit co-factors like Med1, and Brd4 and are associated with the transcription of ependymoma oncogenes (Notch1 and Ccnd1). We leveraged machine learning models trained on FOs in other cancers to identify critical intrinsically disordered domains (IDRs) within ZFTA-RELA. A series of mutagenesis experiments were conducted to determine IDRs important for condensate formation, transcription, and tumor initiation. We also performed NMR spectroscopy to unravel the protein structure of ZFTA-RELA zinc finger binding domains.

RESULTS

We demonstrate that transcriptional condensate formation of ZFTA-RELA is an important cellular phenotype that is tightly linked with oncogenic transcription and tumor initiation. Further, we identify key residues within the zinc finger domain of ZFTA that are required for DNA binding of oncogenic target genes and condensate formation. Deletion of the key IDRs within ZFTA-RELA disrupts condensates and abolishes transcriptional activation and tumorigenesis. We also show that condensate formation is an underlying feature found across all other ZFTA-fusion oncoproteins, providing a model to understand how ZFTA FOs drive cancer.

CONCLUSION

Our studies provide mechanistic insights into the biophysical and structural basis of ZFTA fusion oncoproteins. These findings provide a framework to develop druggable strategies through targeting ZFTA FO zinc finger domains or disruption of oncogenic condensates.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES